Literature DB >> 16136465

Detection of chlamydial bodies and antigens in the central nervous system of patients with multiple sclerosis.

Subramaniam Sriram1, Asa Ljunggren-Rose, Song-Yi Yao, William O Whetsell.   

Abstract

To examine a possible relationship between Chlamydia pneumoniae infection and multiple sclerosis (MS), we undertook an immunohistochemical (IHC), molecular, and ultrastructural comparison of central nervous system (CNS) tissue and cerebrospinal fluid (CSF) sediment from patients with MS and control individuals with other neurological diseases (ONDs). In 7 of 20 MS cases, IHC staining was seen in association with ependymal surfaces and periventricular regions of formalin-fixed brain tissue, by use of 3 different antichlamydial antibodies. There was no staining with any of the 3 antichlamydial antibodies in formalin-fixed brain tissue from OND controls (n=17). With available frozen CNS tissue, polymerase chain reaction (PCR) studies for the presence of C. pneumoniae genes were performed. The presence of a PCR signal was confirmed in 5 of 8 MS cases and in 3 of 18 OND controls. In an examination of CSF sediment by electron microscopy, we observed electron-dense structures resembling chlamydial organisms in CSF sediments from 11 of 20 MS cases and 2 of 12 OND controls. The presence of immunogold-labeled electron-dense bodies was correlated with the presence of a PCR signal in 10 of 11 MS cases. Results of studies using these different approaches support our suspicion of the presence of chlamydial organisms in the CNS, in a subset of patients with MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16136465     DOI: 10.1086/431518

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Increased prevalence of multiple sclerosis among COPD patients and their first-degree relatives: a population-based study.

Authors:  Arne Egesten; Lena Brandt; Tomas Olsson; Fredrik Granath; Malin Inghammar; Claes-Göran Löfdahl; Anders Ekbom
Journal:  Lung       Date:  2008-03-20       Impact factor: 2.584

2.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

3.  Chlamydophila pneumoniae PknD exhibits dual amino acid specificity and phosphorylates Cpn0712, a putative type III secretion YscD homolog.

Authors:  Dustin L Johnson; James B Mahony
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

4.  Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain.

Authors:  Christine J Hammond; Loretta R Hallock; Raymond J Howanski; Denah M Appelt; C Scott Little; Brian J Balin
Journal:  BMC Neurosci       Date:  2010-09-23       Impact factor: 3.288

Review 5.  Exploring the "Multiple-Hit Hypothesis" of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat.

Authors:  Kristin L Patrick; Samantha L Bell; Chi G Weindel; Robert O Watson
Journal:  Front Cell Infect Microbiol       Date:  2019-05-28       Impact factor: 5.293

Review 6.  The atypical pneumonias: clinical diagnosis and importance.

Authors:  B A Cunha
Journal:  Clin Microbiol Infect       Date:  2006-05       Impact factor: 8.067

7.  Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls.

Authors:  Yi-Wei Tang; Subramaniam Sriram; Haijing Li; Song-yi Yao; Shufang Meng; William M Mitchell; Charles W Stratton
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

8.  In silico synteny based comparative genomics approach for identification and characterization of novel therapeutic targets in Chlamydophila pneumoniae.

Authors:  Bilachi S Ravindranath; Venkatappa Krishnamurthy; Venkatarangaiah Krishna; Sunil Kumar C
Journal:  Bioinformation       Date:  2013-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.